Claims
- 1. A method for applying a wound dressing as a tissue adhesive to aid in healing open wounds, said method consisting essentially of the steps of:
- a. debriding and cleansing an open wound site with a saline solution;
- b. drying surrounding skin, leaving the open wound moist;
- c. applying, generously, a treatment compound of a hydrolyzed type I collagen having an average molecular weight ranging from 1,000 to 10,000 in a form selected from the group consisting of a powder, gel, paste, and film directly to the wound site and surrounding area, wherein said treatment compound comprises a tissue adhesive medical hydrolysate having uncleaved peptide ends;
- d. applying a nonsticking dressing; and
- e. repeating steps b-d at least once every twenty-four hours, wherein removal of previously applied hydrolyzed type I collagen becomes unnecessary.
- 2. The method as defined in claim 1, wherein said hydrolyzed type I collagen has a molecular weight ranging from 2000 to 4000.
- 3. The method as defined in claim 2, wherein said hydrolyzed type I collagen has a molecular weight ranging from 2500 to 2800.
- 4. The method as defined in claim 1, wherein said hydrolyzed type I collagen is derived from a bovine source.
- 5. The method as defined in claim 4, wherein said bovine source is calves under one year of age.
- 6. The method as defined in claim 1, wherein said tissue adhesive medical hydrolysate is in powdered form.
- 7. The method as defined in claim 1, wherein said tissue adhesive medical hydrolysate is in gel form comprising approximately 25-6% hydrolyzed Type I collagen and approximately 40-75% water, weight to volume.
- 8. The method as defined in claim 7, wherein said gel comprises 60% hydrolyzed Type I collagen and approximately 40% water, weight to volume.
- 9. The method as defined in claim 1, wherein said tissue adhesive thin layer of hydrolyzed Type I collagen mixed with water and a cross-linking agent.
- 10. A wound dressing composition including a tissue adhesive medical hydrolysate consisting essentially of a hydrolyzed Type I collagen having an average molecular weight ranging from 1,000 to 10,000 and having a physical form selected from the group consisting of a powder, gel, paste, and film, and having uncleaved peptide ends.
- 11. The wound dressing as defined in claim 10, wherein said hydrolyzed type I collagen has a molecular weight ranging from 2000 to 4000.
- 12. The wound dressing as defined in claim 11, wherein said hydrolyzed type I collagen has a molecular weight ranging from 2500 to 2800.
- 13. The wound dressing as defined in claim 10, wherein said hydrolyzed type I collagen is derived from a bovine source.
- 14. The wound dressing as defined in claim 13, wherein said bovine source is calves under one year of age.
- 15. The wound dressing as defined in claim 10, wherein said tissue adhesive medical hydrolysate is in powdered form.
- 16. The wound dressing as defined in claim 10, wherein said tissue adhesive medical hydrolysate is in gel form comprising approximately 25-60% hydrolyzed Type I collagen, and approximately 40-75% water, weight to volume.
- 17. The wound dressing as defined in claim 10, wherein said gel comprises 60% hydrolyzed Type I collagen and approximately 40% water, weight to volume.
- 18. The wound dressing as defined in claim 10, wherein said tissue adhesive medical hydrolysate is in film form made by removing water from a thin layer of hydrolyzed Type I collagen mixed with water and a cross-linking agent selected from the group consisting of humectant, propylene glycol, sorbitol, and glycerine.
- 19. The wound dressing as defined in claim 18, wherein said film further comprises a medicinal agent.
- 20. The wound dressing as defined in claim 17, wherein a preservative selected from the group consisting of benzyl alcohol and paraben is added.
CROSS REFERENCE TO RELATED APPLICATION
This is a continuation-in-part of application Ser. No. 09/032,031 filed Feb. 27, 1998, and now abandoned or Oct. 14, 1999.
US Referenced Citations (16)
Foreign Referenced Citations (2)
Number |
Date |
Country |
0 450 671 A1 |
Oct 1991 |
EPX |
0 530 982 A1 |
Mar 1993 |
EPX |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
032031 |
Feb 1998 |
|